A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring

American Heart Journal

Volumn 151, Issue 3, 2006, Pages 754.e7-754.e17

  Macchia, Alejandro ^a   Levantesi, Giacomo ^a   Borrelli, Giovanna ^a   Franzosi, Maria Grazia ^c   Maggioni, Aldo Pietro ^b   Marfisi, Rosamaria ^a   Scarano, Marco ^a   Tavazzi, Luigi ^d   Tognoni, Gianni ^a   Valagussa, Franco ^e   Marchioli, Roberto ^a  

^a Consorzio Mario Negri Sud ^*  (Italy)

^b ANMCO RESEARCH CENTER   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e SAN GERARDO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GRUPPO ITALIANO PER LO STUDIO DELLA SOPRAVVIVENZA NELL INFARTO MIOCARDICO; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEX ROLE; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 33344471514     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.10.023     Document Type: Article

References (44)

1. S.M. Haffner, R. D'Agostino Jr, and L. Mykkanen Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study Diabetes Care 22 1999 562 568
2. F.N. Brand, R.D. Abbott, and W.B. Kannel Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study Diabetes 38 1989 504 509
3. W.H. Pan, L.B. Cedres, and K. Liu Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women Am J Epidemiol 123 1986 504 516
4. J. Stamler, O. Vaccaro, J.D. Neaton, and D. Wentworth Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16 1993 434 444
5. B. Balkau, M. Shipley, and R.J. Jarrett High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study Diabetes Care 21 1998 360 367
6. B.J. Goldstein Insulin resistance: from benign to type 2 diabetes mellitus Rev Cardiovasc Med 4 Suppl 6 2003 S3 S10
7. J.H. Warram, B.C. Martin, and A.S. Krolewski Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents Ann Intern Med 113 1990 909 915
8. M.A. Charles, A. Fontbonne, and N. Thibult Risk factors for NIDDM in white population. Paris prospective study Diabetes 40 1991 796 799
9. R.A. Sicree, P.Z. Zimmet, and H.O.M. King Plasma insulin response among Nauruans: prediction of deterioration in glucose tolerance over 6 years Diabetes 36 1987 179 186
10. S. Lillioja, D.M. Mott, and M. Spraul Insulin resistance and insulin secretory dysfunction as precursors of non-insulin dependent diabetes mellitus. Prospective studies of Pima Indians N Engl J Med 329 1993 1988 1992
11. S.J. Hunter, and W.T. Garvey Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system Am J Med 105 1998 331 345
12. W.T. Cefalu Insulin resistance: cellular and clinical concepts Exp Biol Med 226 2001 13 26
13. A.D. Liese, E.J. Mayer-Davis, and S.M. Haffner Development of the multiple metabolic syndrome: an epidemiologic perspective Epidemiol Rev 20 1998 157 172
14. M.P. Stern, K. Williams, and S.M. Haffner Do we need the oral glucose tolerance test to identify future cases of type 2 diabetes? Diabetes Care 26 2003 940 941
15. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
16. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 15 1998 539 553
17. D. Einhorn, G.M. Reaven, and R.H. Cobin American College of Endocrinology position statement on the insulin resistance syndrome Endocr Pract 9 2003 237 252
18. D.E. Laaksonen, H.M. Lakka, and L.K. Niskanen Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study Am J Epidemiol 156 2002 1070 1077
19. C. Lorenzo, M. Okoloise, and K. Williams The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study Diabetes Care 26 2003 3153 3159
20. M. Mitka Metabolic syndrome recasts old cardiac, diabetes risk factors as a "new" entity JAMA 291 2004 2062 2063
21. GISSI-Prevenzione Investigators Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial Lancet 354 1999 447 455
22. D.W. Hosmer, and S. Lemeshow Applied logistic regression 1989 John Wiley & Sons, Inc New York (NY)
23. P. Bruzzi, S.B. Green, and D.P. Byar Estimating the population attributable risk for multiple risk factors using case-control data Am J Epidemiol 122 1985 904 914
24. S.D. Walter The distribution of Levin's measure of attributable risk Biometrika 62 1975 371 374
25. L.S. Engel, W.H. Chow, and T.L. Vaughan Population attributable risks of esophageal and gastric cancers J Natl Cancer Inst 95 2003 1404 1413
26. R. Lowry Clinical Calculator 1 from an observed sample: estimates of population prevalence, sensitivity, specificity, predictive values, and likelihood ratios Available from http://faculty.vassar.edu/lowry/clin1.html. 2001
27. A.J. Silman Epidemiological studies: a practical guide 1995 Cambridge University Press Cambridge (UK)
28. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristics curves: a nonparametric approach Biometrics 44 1988 837 845
29. A.C. Justice, K.E. Covinsky, and J.A. Berlin Assessing the generalizability of prognostic information Ann Intern Med 130 1999 515 524
30. J.A. Hanley, and B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 1982 29 36
31. J. Neter, and W. Wasserman Multiple regression Applied linear statistical models 1974 Irwin Homewood (Ill) 214 272
32. D.R. Cox Regression models and life tables J R Stat Soc B 34 1972 187 220
33. F.E. Harrell Jr, K.L. Lee, and D.B. Mark Multivariable prognostic models: issue in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
34. B. Efron, and R. Tibshirani An introduction to the Bootstrap 1993 Chapman and Hall New York (NY)
35. SAS Institute Inc., Cary, NC, U.S.A. SAS Institute Inc. SAS/STAT Users Guide, Version 8 1999 SAS Institute Inc Cary (NC)
36. S.M. Grundy, H.B. Brewer Jr, and J.I. Cleeman Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 2004 433 438
37. S. Genuth, K.G. Alberti, and P. Bennett Follow-up report on the diagnosis of diabetes mellitus Diabetes Care 26 2003 3160 3167
38. P.W. Wilson, R.B. D'Agostino, and D. Levy Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
39. M.P. Stern, K. Williams, and S.M. Haffner Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 136 2002 575 581
40. G. Levantesi, A. Macchia, and R.M. Marfisi Metabolic syndrome and risk of cardiovascular events after myocardial infarction J Am Coll Cardiol 46 2005 277 283
41. W.C. Knowler, E. Barrett-Connor, and S.E. Fowler Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403
42. F.B. Hu, J.E. Manson, and M.J. Stampfer Diet, lifestyle, and the risk of type 2 diabetes mellitus in women N Engl J Med 345 2001 790 797
43. J. Tuomilehto, J. Lindstrom, and J.G. Eriksson Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N Engl J Med 344 2001 1343 1350
44. L.L. Watkins, A. Sherwood, and M. Feinglos Effects of exercise and weight loss on cardiac risk factors associated with syndrome X Arch Intern Med 163 2003 1889 1895